Noradrenaline (also known as norepinephrine) is a medication used to treat very low blood pressure in critically ill patients. It helps to increase blood pressure by tightening blood vessels. In this trial, researchers are studying whether using less of this medication in patients who have cardiogenic shock (a condition where the heart suddenly can’t pump enough blood) after a heart attack might lead to better outcomes. This medication is typically given through an intravenous (IV) line directly into the bloodstream.

Acute myocardial infarction with cardiogenic shock – A severe condition where a heart attack leads to the heart’s sudden inability to pump enough blood to meet the body’s needs. The heart attack damages a large portion of heart muscle, causing a dramatic drop in blood pressure and reduced blood flow to vital organs. This condition develops when heart muscle damage is extensive enough that the heart cannot maintain adequate circulation. The reduced blood flow affects multiple organs, leading to their dysfunction. As the condition progresses, it creates a cycle where poor heart function and reduced organ perfusion worsen each other.